SUFA(000777)

Search documents
中核科技(000777) - 2021 Q2 - 季度财报
2021-08-26 16:00
Financial Performance - The company's operating revenue for the first half of 2021 was CNY 747,362,547.80, representing a 55.15% increase compared to CNY 481,716,088.51 in the same period last year[20]. - The net profit attributable to shareholders of the listed company decreased by 21.15% to CNY 18,351,205.05 from CNY 23,272,120.62 year-on-year[20]. - The net cash flow from operating activities was negative at CNY -124,199,731.23, a decline of 79.38% compared to CNY -69,236,806.77 in the previous year[20]. - The total assets at the end of the reporting period increased by 11.54% to CNY 2,753,032,867.74 from CNY 2,468,148,430.86 at the end of the previous year[20]. - The basic earnings per share fell by 21.25% to CNY 0.0478 from CNY 0.0607 in the same period last year[20]. - The weighted average return on net assets decreased to 1.18% from 1.57% year-on-year[20]. - The revenue from valve manufacturing accounted for 98.28% of total operating revenue, amounting to ¥734,529,516.32, which is a 53.91% increase year-on-year[37]. - The nuclear power valve segment saw significant growth, with revenue increasing by 772.72% to ¥156,937,012.68, compared to ¥17,982,555.36 in the previous year[37]. - The gross profit margin for valve manufacturing decreased by 7.09% to 17.70% compared to the previous year[40]. - The company reported a significant increase in investment income, amounting to 38.25 million, representing 225.18% of total profit[43]. Research and Development - The company increased its R&D investment by 88.10% to ¥33,527,337.31, reflecting a commitment to enhancing its technological capabilities[34]. - Research and development expenses for the first half of 2021 were CNY 33,527,337.31, compared to CNY 17,824,041.59 in the same period of 2020, reflecting an increase of approximately 88.1%[147]. - The company is advancing the development of a steam isolation valve with a gas-liquid linkage actuator to address critical technical challenges[28]. Market and Sales - The domestic valve sales totaled ¥620,370,251.31, accounting for 83.01% of total revenue, with a year-on-year growth of 42.08%[39]. - The export valve sales surged by 181.03% to ¥114,159,265.01, indicating successful international market expansion[39]. - The company is actively participating in the "Belt and Road" initiative, enhancing its overseas sales network and accelerating international certifications[29]. - The company is focusing on high-end valve markets, particularly in nuclear power and petrochemical sectors, which are expected to maintain strong demand in the coming years[29]. - The company is focusing on expanding its market share through new product development and technological advancements[87]. Financial Position and Assets - Accounts receivable rose to 888.30 million, accounting for 32.27% of total assets, an increase of 4.40% from the previous year[46]. - The company’s inventory increased to 508.84 million, reflecting a rise in raw materials and finished goods due to higher order volumes[46]. - Short-term borrowings increased to 240.60 million, representing 8.74% of total liabilities, primarily to meet working capital needs[46]. - The company's total investment during the reporting period was ¥432,354,874.18, representing a 15.77% increase compared to ¥373,460,312.56 in the same period last year[51]. - The company reported restricted cash of ¥13,636,240.10, which is related to guarantees and deposits for more than three months[50]. Corporate Governance and Compliance - The company has not declared any cash dividends or bonus shares for the reporting period[6]. - The company has not engaged in any securities or derivative investments during the reporting period[52][53]. - The company did not sell any significant assets or equity during the reporting period[54][55]. - The company has not experienced any significant changes in the measurement attributes of its major assets during the reporting period[49]. - The company has not reported any major lawsuits or regulatory penalties during the reporting period, indicating a stable legal standing[84]. - The company has not engaged in any non-operating fund occupation by major shareholders or related parties during the reporting period[79]. - The company has not issued any non-standard audit reports for the half-year financial report, maintaining compliance with auditing standards[81]. Strategic Initiatives - The company is implementing measures to enhance market information collection and improve sales management to address competitive risks[60]. - The company plans to enhance risk prevention measures for overseas projects and conduct thorough risk assessments for significant projects[59]. - The overall financial strategy includes a focus on mergers and acquisitions to enhance market share and operational capabilities[172]. Shareholder Information - The total number of shareholders at the end of the reporting period was 65,222, with significant shareholders including China Nuclear Suzhou Valve Co., Ltd. holding 17.77% and China National Nuclear Corporation holding 9.25%[124]. - The company approved a stock incentive plan, granting 3.18 million restricted shares at a price of 7.55 yuan per share[110]. - The company completed the registration of the first grant of the 2020 restricted stock incentive plan on May 19, 2021, granting 3.18 million shares at an exercise price of 7.55 CNY per share, increasing total shares from 383,417,593 to 386,597,593[123]. Environmental and Social Responsibility - The company has established an EHS management system and successfully passed ISO14001 and ISO45001 certification in 2021, indicating a commitment to environmental and occupational health safety[74]. - The company actively participated in poverty alleviation efforts, purchasing over 260,000 CNY worth of local agricultural products to support impoverished households[75]. - The company has implemented measures for COVID-19 prevention, including daily temperature checks and distribution of protective equipment to employees[75].
中核科技(000777) - 2020 Q4 - 年度财报
2021-04-27 16:00
Financial Performance - The company's operating revenue for 2020 was ¥1,166,857,141.32, a decrease of 7.82% compared to ¥1,265,879,384.10 in 2019[17]. - The net profit attributable to shareholders for 2020 was ¥104,630,026.73, down 22.93% from ¥135,758,936.11 in 2019[17]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥86,446,129.18, a decline of 30.23% from ¥123,899,240.38 in 2019[17]. - The net cash flow from operating activities was -¥15,127,502.66, an improvement of 80.84% compared to -¥78,968,083.69 in 2019[17]. - The basic earnings per share for 2020 was ¥0.2729, a decrease of 22.93% from ¥0.3541 in 2019[17]. - The total assets at the end of 2020 were ¥2,468,148,430.86, an increase of 2.05% from ¥2,418,590,638.12 at the end of 2019[17]. - The net assets attributable to shareholders at the end of 2020 were ¥1,544,303,935.19, up 4.87% from ¥1,472,613,959.23 at the end of 2019[17]. - The weighted average return on net assets for 2020 was 6.86%, down from 9.53% in 2019, a decrease of 2.67%[17]. - The company reported a total revenue of 10,277.285407 million RMB for the year 2020[172]. Dividend Policy - The company plans to distribute a cash dividend of 0.82 RMB per 10 shares to all shareholders, based on a total of 383,417,593 shares[4]. - For the year 2020, the company proposed a cash dividend of 0.82 yuan (including tax) per 10 shares, amounting to a total of 31,440,242.63 yuan, with no capital reserve fund conversion into share capital[91]. - The cash dividend for 2020 represented 30.05% of the net profit attributable to the company's ordinary shareholders, which was 104,630,026.73 yuan[90]. - The company maintained a stable dividend distribution policy, ensuring that minority shareholders had the opportunity to express their opinions and that their legal rights were fully protected[87]. - The company has not proposed any capital reserve fund conversion into share capital for the past three years[88]. - The company’s cash dividend policy is compliant with the company’s articles of association and the resolutions of the shareholders' meeting[87]. Corporate Governance - The company emphasizes the importance of accurate financial reporting, with key personnel affirming the completeness and truthfulness of the annual report[3]. - The company has implemented a modern corporate governance structure since its listing in 1997, enhancing operational efficiency and management practices[32]. - The company’s independent directors fulfilled their responsibilities in the decision-making process regarding the cash dividend policy[87]. - The company has maintained a continuous relationship with its accounting firm for 6 years, with the current audit partners having 1 and 4 years of service respectively[103]. - The company has strengthened its governance structure to protect the rights of shareholders and creditors, ensuring compliance and accountability[132]. Market and Business Strategy - The company has maintained its core business in the research, production, and sales of industrial valves, with a focus on high-end markets such as nuclear engineering and petrochemicals[26]. - The company is actively expanding its international market presence, participating in "Belt and Road" projects, and accelerating overseas certification processes[27]. - The company aims to transition from manufacturing to service-oriented production, gradually moving towards the mid-to-high-end market[73]. - The company’s strategic focus includes improving product quality and brand competitiveness rather than competing solely on price[73]. - The company is positioned to benefit from the ongoing structural adjustments in the valve industry, which may lead to the elimination of inefficient enterprises[73]. Research and Development - R&D investment totaled ¥54.06 million, with four invention patents authorized during the year[35]. - The company is focusing on R&D to enhance product technology and is collaborating with international manufacturers to produce high-value-added products[73]. - Key research projects, including the development of pressure stabilizers and safety valves, will be accelerated to address critical technology bottlenecks[76]. - The company has established strong technical innovation capabilities, with several key valve products leading in the domestic market, particularly in nuclear power applications[31]. Risk Management - Risks associated with international operations, including market complexity and trade tensions, are being addressed through enhanced risk assessment and management strategies[78]. - Cash flow risks due to slow turnover of certain funds are being mitigated by improving accounts receivable management and optimizing inventory[79]. - The company faces market competition risks from numerous private enterprises and is focusing on strengthening market research and sales team capabilities[79]. Social Responsibility - The company donated 5,000 masks and 2,000 gloves to Spanish healthcare institutions during the pandemic, receiving high praise from partners[141]. - The company mobilized employees to donate nearly 28,000 yuan for charity and participated in various social responsibility initiatives during the pandemic[147]. - The company has focused on environmental responsibility, aiming to build a resource-saving and environmentally friendly enterprise[131]. - The company has engaged in community support, including sending educational materials to special needs children and participating in blood donation drives[144]. Employee Engagement - The company has actively pursued employee welfare initiatives, including health checks and insurance coverage, benefiting over 50 employees in 2020[136]. - The company conducted a total of 1,848 training sessions, accumulating 23,154 hours of training, averaging 21.7 hours per employee[198]. - The company has established a performance-based salary management system for senior management, linking remuneration to operational performance[197]. Related Party Transactions - The company engaged in significant related party transactions, with transaction amounts and pricing principles detailed in the report[111]. - The company reported a total of 1,496.3 million yuan in related party transactions, accounting for 1.29% of the total transaction amount[112]. - The company’s related party transactions included sales of valves and procurement of materials, with specific amounts and percentages disclosed[113].
中核科技(000777) - 2021 Q1 - 季度财报
2021-04-27 16:00
中核苏阀科技实业股份有限公司 2021 年第一季度报告全文 中核苏阀科技实业股份有限公司 2021 年第一季度报告 2021 年 04 月 1 中核苏阀科技实业股份有限公司 2021 年第一季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人彭新英、主管会计工作负责人匡小兰及会计机构负责人(会计主 管人员)王静声明:保证季度报告中财务报表的真实、准确、完整。 2 中核苏阀科技实业股份有限公司 2021 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | 营业收入(元) | 260,283,798.67 | 131,125,342.78 | 98.50% | | 归属于上市公司股东的净利润(元) | -5,117,741.01 | ...
中核科技(000777) - 2020 Q3 - 季度财报
2020-10-29 16:00
Financial Performance - Operating revenue decreased by 7.35% to CNY 298,345,042.16 for the current period, and by 17.95% to CNY 780,061,130.67 year-to-date[9] - Net profit attributable to shareholders decreased by 36.69% to CNY 29,567,135.09 for the current period, and by 41.61% to CNY 52,839,255.71 year-to-date[9] - Basic earnings per share decreased by 36.70% to CNY 0.0771 for the current period, and by 41.61% to CNY 0.1378 year-to-date[9] - Total operating revenue for the current period is ¥780,061,130.67, down from ¥950,735,473.72 in the previous period, representing a decrease of approximately 17.9%[45] - Net profit for the current period is ¥52,839,255.71, compared to ¥90,490,348.64 in the previous period, reflecting a decline of approximately 41.6%[47] - The total profit for the current period is ¥53,524,987.13, down from ¥88,932,087.74, a decrease of approximately 39.7%[47] - The company reported a total comprehensive income of ¥46,330,890.74, down from ¥94,637,212.60, a decline of about 51.1%[48] Assets and Liabilities - Total assets increased by 4.16% to CNY 2,519,104,038.53 compared to the end of the previous year[9] - Total liabilities rose to CNY 1,040,657,222.09, up from CNY 945,976,678.89, indicating an increase of about 10.03%[31] - Current liabilities totaled CNY 974,730,042.99, compared to CNY 870,741,676.23, marking an increase of approximately 11.93%[31] - Non-current liabilities decreased to CNY 65,927,179.10 from CNY 75,235,002.66, a decline of about 12.43%[31] - Owner's equity increased to CNY 1,478,446,816.44 from CNY 1,472,613,959.23, showing a slight growth of approximately 0.39%[32] - Cash and cash equivalents decreased to CNY 200,464,490.12 from CNY 262,348,588.36, a decline of about 23.59%[32] - Accounts receivable increased to CNY 795,903,644.68 from CNY 748,213,709.23, reflecting a growth of approximately 6.36%[32] - Inventory rose to CNY 397,521,103.17 from CNY 352,737,123.98, indicating an increase of about 12.67%[32] - Long-term equity investments increased to CNY 471,184,390.83 from CNY 416,378,431.04, a growth of approximately 13.14%[34] Cash Flow - Net cash flow from operating activities increased significantly by 272.76% to CNY 42,872,743.63 for the current period[9] - The net cash flow from operating activities was -26,364,063.14 CNY, an improvement from -201,701,490.63 CNY in the same period last year[55] - Cash received from the sale of goods and services increased to 693,108,912.83 CNY, up from 628,632,885.75 CNY year-over-year, representing an increase of approximately 10.3%[55] - The total cash inflow from operating activities was 719,446,967.68 CNY, compared to 644,429,329.90 CNY in the previous year, marking a growth of about 11.7%[55] - Cash outflow for purchasing goods and services decreased to 560,281,969.59 CNY from 636,256,678.88 CNY, a reduction of approximately 11.9%[55] - The net cash flow from investing activities was -5,941,310.04 CNY, a decline from 36,429,930.30 CNY in the previous year[56] - Cash inflow from investment activities totaled 26,618,977.71 CNY, down from 50,089,970.56 CNY year-over-year, indicating a decrease of about 46.8%[56] - Cash inflow from financing activities was 213,900,000.00 CNY, compared to 122,601,167.67 CNY in the same period last year, reflecting an increase of approximately 74.5%[56] - The ending cash and cash equivalents balance was 190,074,287.07 CNY, compared to 116,782,105.79 CNY at the end of the same period last year, representing an increase of about 62.7%[56] Shareholder Information - The total number of shareholders at the end of the reporting period was 69,498[13] - The largest shareholder, China Nuclear Suzhou Valve Co., Ltd., holds 17.92% of the shares[13] - No repurchase transactions were conducted by the top 10 shareholders during the reporting period[14] Other Financial Metrics - The weighted average return on equity decreased to 1.98%, down by 1.35% compared to the previous year[9] - The company reported non-recurring gains and losses totaling CNY 10,189,066.72 for the year-to-date[10] - Financial expenses increased by 42.64% to ¥6,691,032.02, attributed to exchange losses from the appreciation of the RMB against the USD[18] - The company recorded a 4522.97% increase in asset disposal gains to ¥897,162.59, resulting from higher non-current asset disposal income[17] - The company has no significant non-operating guarantees or overdue commitments during the reporting period[19]
中核科技(000777) - 2020 Q2 - 季度财报
2020-08-27 16:00
Financial Performance - The company's operating revenue for the first half of 2020 was ¥481,716,088.51, a decrease of 23.38% compared to ¥628,726,791.18 in the same period last year[17]. - The net profit attributable to shareholders was ¥23,272,120.62, down 46.85% from ¥43,789,232.30 year-on-year[17]. - The net profit after deducting non-recurring gains and losses was ¥17,395,306.35, a decline of 54.97% compared to ¥38,632,322.79 in the previous year[17]. - The company achieved a revenue of CNY 481.72 million in the reporting period, a decrease of 23.38% compared to CNY 628.73 million in the same period last year, primarily due to the impact of the pandemic and lower production capacity during the initial recovery phase[37]. - The company reported a net profit for the first half of 2020 of CNY 22,513,800.79, a decrease of 50.1% compared to CNY 44,924,527.47 in the same period of 2019[145]. - The company reported a total comprehensive income of CNY 13,710,548.06 for the first half of 2020, down from CNY 52,158,687.51 in the same period of 2019[146]. Cash Flow and Financial Position - The net cash flow from operating activities improved to -¥69,236,806.77, a 60.86% increase from -¥176,885,331.39 in the same period last year[17]. - The company reported a net cash inflow from financing activities of CNY 57,208,040.91, an increase of 40.50% year-on-year, mainly due to increased short-term borrowings[44]. - The company's cash and cash equivalents increased by 71.04% to CNY -35,780,452.77, driven by improved cash flow from operating and financing activities[44]. - The net cash flow from operating activities was -72,241,248.76 CNY, an improvement from -178,828,711.82 CNY in the previous period[153]. - The total cash and cash equivalents at the end of the period decreased to 199,144,497.75 CNY from 244,705,593.40 CNY[153]. Assets and Liabilities - Total assets at the end of the reporting period were ¥2,506,632,279.58, reflecting a 3.64% increase from ¥2,418,590,638.12 at the end of the previous year[17]. - The company's total liabilities increased to CNY 1,019,461,955.96 from CNY 945,976,678.89, reflecting an increase of about 7.7%[133]. - The company's short-term borrowings rose to CNY 270,900,000.00, representing 10.81% of total assets, due to the need for working capital[48]. - The company's total liabilities decreased to 672,590,000 CNY from 744,740,000 CNY, reflecting a reduction of approximately 9.7%[164]. Research and Development - The company established a joint research and development center with East China University of Science and Technology, increasing its technology innovation platforms to six[38]. - The company authorized 14 patents during the reporting period, including 2 invention patents, and applied for 38 patents, with 19 being invention patents[38]. - Research and development investment increased by 22.47% to CNY 17,824,041.59, reflecting a significant increase in funding for R&D projects[44]. Operational Challenges - The ongoing COVID-19 pandemic has negatively impacted the industry, leading to production slowdowns and increased competition in the domestic market[25]. - The company faced challenges such as delayed orders and inventory buildup due to the pandemic, affecting overall operational efficiency[25]. - Revenue from nuclear engineering valves dropped by 77.59% year-on-year, primarily due to the impact of the nuclear power project cycle[44]. Shareholder Information - The company reported a total of 383,417,593 shares outstanding, with 100% being unrestricted shares[109]. - The largest shareholder, China Nuclear Suzhou Valve Co., Ltd., holds 17.92% of the shares, totaling 68,715,360 shares[112]. - The second largest shareholder, China National Nuclear Corporation, owns 9.33% of the shares, amounting to 35,753,819 shares[112]. Corporate Governance and Compliance - The company did not distribute cash dividends or issue bonus shares during this reporting period[6]. - The half-year financial report was not audited[70]. - The company reported no significant litigation or arbitration matters during the reporting period[72]. - The company did not engage in any significant equity or non-equity investments during the reporting period[55][56]. Social Responsibility - The company actively participated in poverty alleviation efforts, purchasing local agricultural products worth nearly 260,000 yuan[96]. - The company donated 9,800 masks and 2,000 pairs of gloves to overseas clients during the pandemic[97]. Accounting and Financial Reporting - The financial statements are prepared in accordance with the Accounting Standards for Business Enterprises, reflecting the company's financial position as of June 30, 2020[171]. - The company has made no significant changes to its accounting policies during the reporting period[100]. - The company’s accounting currency is Renminbi (RMB)[174].
中核科技(000777) - 2020 Q1 - 季度财报
2020-04-29 16:00
中核苏阀科技实业股份有限公司 2020 年第一季度报告全文 中核苏阀科技实业股份有限公司 2020 年第一季度报告 2020 年 04 月 1 中核苏阀科技实业股份有限公司 2020 年第一季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人彭新英、主管会计工作负责人陆振学及会计机构负责人(会计主 管人员)王静声明:保证季度报告中财务报表的真实、准确、完整。 2 中核苏阀科技实业股份有限公司 2020 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | 营业收入(元) | 131,125,342.78 | 305,604,373.91 | -57.09% | | 归属于上市公司股东的净利润(元) | -18,162,885.82 ...
中核科技(000777) - 2019 Q4 - 年度财报
2020-04-29 16:00
Financial Performance - The company's operating revenue for 2019 was CNY 1,265,879,384.10, representing a 3.23% increase compared to CNY 1,226,310,462.97 in 2018[18]. - The net profit attributable to shareholders for 2019 was CNY 135,758,936.11, a 31.82% increase from CNY 102,986,326.82 in 2018[18]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 123,899,240.38, up 41.39% from CNY 87,626,646.13 in 2018[18]. - The basic earnings per share for 2019 was CNY 0.3541, an increase of 31.83% compared to CNY 0.2686 in 2018[18]. - The total assets at the end of 2019 were CNY 2,418,590,638.12, reflecting a 7.23% increase from CNY 2,255,604,717.35 at the end of 2018[18]. - The net assets attributable to shareholders at the end of 2019 were CNY 1,472,613,959.23, an 8.50% increase from CNY 1,357,228,037.09 at the end of 2018[18]. - The company's total operating revenue for 2019 was ¥1,265,879,384.10, representing a 3.23% increase from ¥1,226,310,462.97 in 2018[45]. - The revenue from valve manufacturing accounted for 98.53% of total operating revenue, amounting to ¥1,247,283,604.09, which is a 4.37% increase from the previous year[45]. - The company reported a total revenue of 1,200 million CNY for the fiscal year 2019, reflecting a year-on-year growth of 15%[105]. - The net profit attributable to shareholders was 150 million CNY, representing an increase of 10% compared to the previous year[105]. - The company reported a total revenue of 3,895.7 million for the year 2019, with a growth rate of 3.08% compared to the previous year[120]. - The company reported a total revenue of 15,056 million yuan for the year 2019, with a 1.00% increase in sales price[122]. Cash Dividends - The company plans to distribute a cash dividend of 1.07 RMB per 10 shares to all shareholders, based on a total of 383,417,593 shares[5]. - The company maintains a stable cash dividend policy, distributing a cash dividend of 0.90 yuan per 10 shares to all shareholders based on the total share capital of 383,417,593 shares as of the end of 2018[93]. - The company distributed cash dividends of 0.40 CNY per 10 shares in 2017, totaling 15,336,703.72 CNY[94]. - In 2018, the cash dividend increased to 0.90 CNY per 10 shares, amounting to 34,507,583.37 CNY[95]. - For 2019, the cash dividend was further raised to 1.07 CNY per 10 shares, totaling 41,025,682.45 CNY[96]. - The cash dividends for 2019 represented 30.22% of the net profit attributable to the company's shareholders[96]. - The total distributable profit for 2019 was 653,669,831.37 CNY, with cash dividends constituting 100% of the profit distribution[97]. - The company has a cash dividend policy that ensures at least 20% of profit distribution is allocated to cash dividends during growth phases[97]. Corporate Governance - The company emphasizes the importance of accurate and complete financial reporting, with key personnel affirming the integrity of the annual report[4]. - The company’s legal representative is Peng Xinying, who oversees the overall operations and governance[13]. - The company operates under the regulatory framework of the Company Law and Securities Law of the People's Republic of China[10]. - The company has committed to avoiding any competition with its controlling shareholder, China Nuclear Industry Group, in its main business activities[99]. - The company has ongoing commitments to fulfill promises made regarding non-competitive practices and related party transactions[100]. - The company’s board of directors was re-elected, with new candidates nominated for both independent and non-independent director positions[154]. - The company elected Chen Guang and Chen Gang as candidates for the seventh supervisory board, approved on February 14, 2019[155]. - The seventh board of directors elected a new chairman and appointed senior management on February 19, 2019[156]. - The company approved several related party transactions throughout 2019, including a significant transaction on December 30, 2019[165]. Research and Development - The company achieved significant progress in R&D, particularly in the development of steam isolation valves and addressing critical technology challenges[28]. - The company has focused on developing high-end special valves, completing several key technology projects during the reporting period[58]. - The company is actively pursuing the localization of key nuclear power valve technologies, achieving notable progress in the development of the main steam isolation valve drive device[41]. - The company is investing 100 million RMB in R&D for new technologies aimed at enhancing product efficiency[195]. Market Expansion - The company expanded its market presence, particularly in nuclear engineering and petrochemical sectors, with increased order intake[29]. - The company achieved a 24.58% year-on-year growth in foreign trade order intake, driven by international market expansion efforts[40]. - The company has established a new office in Xiong'an New Area to capitalize on significant project opportunities, aiming to secure more orders[39]. - The company plans to strengthen domestic and international market development, targeting new orders and expanding into emerging markets, particularly in the Middle East, the US, Europe, and Southeast Asia[83]. - The company is considering strategic acquisitions to enhance its product portfolio and market presence[195]. Financial Position - The company reported a negative net cash flow from operating activities of CNY -78,968,083.69 in 2019, a decrease of 237.21% compared to CNY 57,553,529.58 in 2018[18]. - The weighted average return on equity for 2019 was 9.53%, up from 7.75% in 2018[18]. - The company's monetary funds at the end of 2019 amounted to ¥263,468,694.80, accounting for 10.89% of total assets, a decrease of 1.12% compared to the beginning of the year[65]. - Accounts receivable increased to ¥751,372,096.60, representing 31.07% of total assets, an increase of 0.43% year-on-year due to delayed payments from some customers[65]. - The total cash and cash equivalents decreased by 155.10% year-on-year, attributed to the decline in net cash flow from operating and investment activities[62]. - The company reported a significant increase in financial expenses by 202.27% to CNY 7,525,817.55 due to increased financing costs[57]. - The company has no significant non-operating fund occupation by controlling shareholders or related parties during the reporting period[103]. Social Responsibility - The company emphasizes its corporate social responsibility, focusing on resource conservation and environmental friendliness[139]. - The company invested approximately 260,000 CNY in purchasing local agricultural products to support poverty alleviation efforts in Shizhu County[150]. - The company organized blood donation activities, achieving a total donation volume of nearly 50,000 milliliters, exceeding the set target by 10 times[150]. - The company upgraded pollution control facilities and ensured compliance with environmental standards, with total COD emissions recorded at 5.575 tons against a limit of 8.896 tons[152]. - The company received ISO certifications including ISO9001, ISO14001, and OHSAS18001 to ensure compliance with quality and environmental management standards[147]. - The company is actively involved in community outreach, including nuclear knowledge education programs for local students[150]. Employee and Management Compensation - The total remuneration paid to directors, supervisors, and senior management during the reporting period amounted to 5.22383 million CNY[197]. - The annual allowance for independent directors is set at 80,000 CNY (including tax)[197]. - The decision-making process for senior management remuneration is based on industry averages and company performance goals, with the general manager's base salary serving as a benchmark[196]. - The base salary for senior management is determined to be 60%-90% of the general manager's base salary, while performance-based annual salary is set at 75%-90%[196]. - The current chairman and party secretary, Peng Xinying, received a total pre-tax remuneration of 792,600 CNY[198]. - The company does not have any stock incentive plans for directors and senior management during the reporting period[199]. Industry Context - The company operates in a competitive valve manufacturing industry, which has become a global leader in production capacity and market demand[80]. - The industry is characterized by low concentration, with significant gaps in high-end valve R&D and manufacturing technology compared to foreign counterparts[80]. - Future industry trends indicate ongoing structural adjustments and increased capital operations within the sector[80]. - The company specializes in the production and sales of nuclear fuel, nuclear materials, uranium products, and related nuclear technologies[176].
中核科技(000777) - 2019 Q3 - 季度财报
2019-10-29 16:00
2019 年 10 月 1 中核苏阀科技实业股份有限公司 2019 年第三季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 中核苏阀科技实业股份有限公司 2019 年第三季度报告全文 中核苏阀科技实业股份有限公司 2019 年第三季度报告全文 (000777) 公司负责人彭新英、主管会计工作负责人陆振学及会计机构负责人(会计主 管人员)王静声明:保证季度报告中财务报表的真实、准确、完整。 2 中核苏阀科技实业股份有限公司 2019 年第三季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增减 | | --- | --- | --- | --- | --- | | 总资产(元) | 2,348,224,132.53 | 2,255,604,717.35 | | 4.11% | | 归属于上市公司股东的 ...
中核科技(000777) - 2019 Q2 - 季度财报
2019-08-26 16:00
Financial Performance - The company's operating revenue for the first half of 2019 was ¥628,726,791.18, representing a 15.15% increase compared to ¥546,009,245.15 in the same period last year[17]. - The net profit attributable to shareholders was ¥43,789,232.30, a significant increase of 57.36% from ¥27,826,639.12 in the previous year[17]. - The net profit after deducting non-recurring gains and losses was ¥38,632,322.79, up 69.05% from ¥22,853,258.69 year-on-year[17]. - The company reported a basic earnings per share of ¥0.1142, which is a 57.30% increase compared to ¥0.0726 in the same period last year[17]. - The company's revenue for the reporting period reached RMB 628.73 million, representing a year-on-year increase of 15.15% due to a significant rise in order intake and delivery volume[34]. - The company reported a significant increase in investment income, amounting to RMB 39,741,226.65, which constituted 95.23% of total profit[44]. - The company's sales revenue for the reporting period increased significantly, reaching RMB 620,161,002.69, a year-on-year growth of 20.43%[42]. - The company reported a total comprehensive income of CNY 51,023,392.34 for the first half of 2019, compared to CNY 22,571,325.28 in the same period of 2018, indicating a substantial increase[127]. - The total comprehensive income for the first half of 2019 was 52,158.68 million RMB, showing a decrease of 5.86% compared to the previous period[149]. Assets and Liabilities - The company's total assets at the end of the reporting period were ¥2,333,059,316.73, reflecting a 3.43% increase from ¥2,255,604,717.35 at the end of the previous year[17]. - The company's long-term prepaid expenses increased by 86.9% compared to the beginning of the year, primarily due to the addition of new prepaid projects during the reporting period[27]. - The company's cash and cash equivalents decreased by 45.33% compared to the beginning of the year, mainly due to cash dividend distribution and increased procurement payments and tax payments[27]. - The accounts receivable notes increased by 167% compared to the beginning of the year, primarily due to the collection of accounts receivable that included undated acceptance bills[27]. - The company's total assets included RMB 148,252,318.90 in cash, which accounted for 6.35% of total assets, an increase from 4.92% in the previous year[46]. - Accounts receivable increased to RMB 866,265,628.60, representing 37.13% of total assets, up from 34.70% year-on-year[46]. - The company's total liabilities rose to CNY 956,932,471.58 from CNY 898,376,680.26, indicating an increase of approximately 6.5%[118]. - The company's equity attributable to shareholders increased from CNY 1,357,228,037.09 to CNY 1,376,126,845.15, reflecting a growth of about 1.4%[118]. - The total liabilities at the end of the reporting period were 568,230.00 million RMB, compared to 557,930.00 million RMB at the beginning of the period[150]. Research and Development - The company has established 31 technology advancement projects for 2019, with key projects such as the development of a fast isolation valve for demonstration fast reactors and a sodium valve standard library being actively promoted[35]. - The company obtained 5 authorized patents during the reporting period, all of which are utility model patents, and filed 26 patent applications, including 13 invention patents[35]. - Research and development investment rose to RMB 14,553,904.76, marking a 35.28% increase compared to the previous year[39]. - Research and development expenses for the first half of 2019 were CNY 14,553,904.76, compared to CNY 10,758,675.61 in the same period of 2018, marking an increase of 35.0%[126]. Operational Strategy - The company continues to focus on the research, production, and sales of industrial valves, with key products including gate valves, globe valves, check valves, ball valves, butterfly valves, and control valves[25]. - The company has implemented a production organization model combining "sales-driven production" and "production-driven sales" to optimize its manufacturing process[25]. - The company emphasizes innovation by achieving localization of key valves such as main steam isolation valves and rupture valves, which has led to successful order fulfillment and subsequent project orders[25]. - The company has optimized production resource allocation and implemented a daily planning management model to enhance production efficiency[26]. - The company is focusing on expanding its market presence and enhancing product development strategies[70]. - The company is engaged in ongoing research and development of new technologies to improve operational efficiency[70]. - The company plans to explore potential mergers and acquisitions to strengthen its market position[70]. - The company aims to enhance user data analytics to better understand market trends and customer needs[70]. - The company is actively pursuing strategic partnerships to leverage synergies and drive growth[70]. Financial Management - The company plans not to distribute cash dividends or issue bonus shares for the reporting period[6]. - The company reported a 12.98% increase in operating costs, which was primarily due to the substantial increase in sales revenue during the reporting period[38]. - Financial expenses surged by 140.88% to RMB 4,682,832.03, primarily due to increased interest expenses from short-term borrowings[39]. - The net cash flow from operating activities was -RMB 176,885,331.39, reflecting a 117.20% decline year-on-year[39]. - The cash flow from financing activities resulted in a net inflow of CNY 40.72 million in the first half of 2019, significantly improving from CNY 2.52 million in the first half of 2018[136]. - The cash flow from investment activities showed a net inflow of 13,224,124.33, a recovery from a net outflow of -50,909,068.41 in the previous year[139]. Market and Competition - The valve industry is highly competitive, with increased domestic competition following the escalation of US-China trade tensions[59]. - The company is facing strategic risks due to uncertainties in national policies and industry environment, which may delay capital operation projects[59]. - The company has identified high levels of accounts receivable and slow inventory clearance as potential funding risks[59]. - Environmental regulations are becoming stricter, impacting certain production processes and increasing internal management pressure[59]. Governance and Compliance - The company held its first extraordinary general meeting on February 14, 2019, with an investor participation rate of 0.18%[62]. - The annual general meeting on April 26, 2019, had an investor participation rate of 0.06%[62]. - There were no major litigation or arbitration matters during the reporting period[67]. - The company did not implement any employee stock ownership plans or other incentive measures during the reporting period[68]. - The company did not experience any penalties or rectification issues during the reporting period[67]. - The company has passed the ISO 14001:2004 environmental management system certification, indicating a commitment to environmental protection and compliance with relevant laws[86]. Social Responsibility - In the first half of 2019, the company invested over 250,000 CNY in purchasing local agricultural products to support poverty alleviation efforts in Shizhu County[88]. - The company donated 40,000 CNY to the Hainan Tibetan Autonomous Prefecture Trade Union as part of its targeted poverty alleviation initiatives[88]. - The company plans to continue its charitable activities in the second half of 2019, including blood donation drives and educational outreach programs[90].
中核科技(000777) - 2019 Q1 - 季度财报
2019-04-29 16:00
Financial Performance - The company's operating revenue for Q1 2019 was ¥305,604,373.91, representing an increase of 89.86% compared to ¥160,959,828.32 in the same period last year[9]. - The net profit attributable to shareholders was ¥12,255,851.56, a significant turnaround from a loss of ¥15,695,141.10 in the previous year, marking an increase of 178.09%[9]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥9,772,081.22, compared to a loss of ¥18,246,039.14 last year, reflecting a 153.56% improvement[9]. - The basic earnings per share increased to ¥0.0320 from a loss of ¥0.0409, showing a growth of 178.24%[9]. - The weighted average return on equity improved to 0.90% from -1.24%[9]. - The company reported a net cash flow from operating activities of -¥124,503,471.26, which is a 13.95% decline compared to -¥109,263,149.80 in the same period last year[9]. - The company reported a comprehensive income total of ¥21.79 million, compared to a comprehensive loss of ¥11.28 million in the previous period, reflecting a positive shift[46]. Assets and Liabilities - Total assets at the end of the reporting period were ¥2,213,258,929.83, a decrease of 1.88% from ¥2,255,604,717.35 at the end of the previous year[9]. - The total liabilities decreased to CNY 802,932,949.80 from CNY 862,912,915.83, a reduction of approximately 6.9%[38]. - The total equity attributable to shareholders increased to CNY 1,376,216,630.10 from CNY 1,357,228,037.09, reflecting a growth of 1.4%[33]. - The company's total current assets were 1,489,382,523.95 CNY, while total non-current assets were 766,222,193.40 CNY[57]. - The company's inventory stood at 463,626,503.79 CNY, indicating a stable level of stock[57]. Cash Flow - Cash and cash equivalents decreased by 45.62% to ¥147,478,405.23 due to increased cash payments for raw materials and taxes resulting from a significant rise in orders[16]. - The company's cash and cash equivalents decreased to CNY 147,478,405.23 from CNY 271,176,964.50, representing a decline of 45.4%[30]. - The net cash flow from operating activities was -122,128,092.40 CNY, compared to -108,903,354.74 CNY in the previous year, indicating a decline in cash generation from operations[53]. - Total cash inflow from operating activities was 171,676,199.47 CNY, while cash outflow was 293,804,291.87 CNY, resulting in a cash outflow of 122,128,092.40 CNY[53]. Expenses - Operating costs rose by 76.94% to ¥239,046,599.29, primarily due to the increase in operating revenue[16]. - Sales expenses increased by 81.61% to ¥29,959,447.36, attributed to higher performance rewards for sales personnel and increased logistics costs[16]. - Tax expenses surged by 317.74% to ¥16,601,114.24, mainly due to a significant increase in value-added tax and other related taxes[17]. - Research and development expenses were CNY 8,708,360.72, slightly up from CNY 8,576,345.75, indicating a focus on innovation[39]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 80,357[12]. - The company's legal representative is Peng Xinying[62]. Government Support - The company received government subsidies amounting to ¥2,913,662.86 during the reporting period[10].